These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4323866)

  • 1. Effect of propanidid on peripheral motor function in myasthenics.
    Ellis FR; Harriman DG
    Br J Anaesth; 1971 Feb; 43(2):205. PubMed ID: 4323866
    [No Abstract]   [Full Text] [Related]  

  • 2. The site and mode of action of propanidid on the peripheral motor unit.
    Ellis FR
    Anaesthesist; 1971 Jan; 20(1):19-22. PubMed ID: 4322995
    [No Abstract]   [Full Text] [Related]  

  • 3. Histometric study of neuromuscular junction ultrastructure. I. Myasthenia gravis.
    Santa T; Engel AG; Lambert EH
    Neurology; 1972 Jan; 22(1):71-82. PubMed ID: 4333030
    [No Abstract]   [Full Text] [Related]  

  • 4. Variability of neuromuscular transmission in myasthenia gravis.
    Mayer RF; Williams IR; Snyder DH
    Trans Am Neurol Assoc; 1973; 98():83-6. PubMed ID: 4361779
    [No Abstract]   [Full Text] [Related]  

  • 5. Myasthenia gravis and respiratory failure related to phrenic nerve lesion.
    Valadas A; de Carvalho M
    Muscle Nerve; 2008 Oct; 38(4):1340-1. PubMed ID: 18785183
    [No Abstract]   [Full Text] [Related]  

  • 6. Motor nerve ending disorder in myasthenia gravis.
    Roe RD; Riker WF; Standaert FG
    Neurology; 1988 Feb; 38(2):293-7. PubMed ID: 2829056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kinetics of transmitter release in myasthenia gravis. 3. An electrophysiological analysis of the release of transmitter.
    Bergmans J; Rosselle N; Verheyen G; Schellens L
    Electromyogr Clin Neurophysiol; 1973; 13(2):145-73. PubMed ID: 4354573
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of serum and serum globulin of patients with myasthenia gravis on neuromuscular transmission.
    Namba T; Grob D
    Neurology; 1969 Feb; 19(2):173-84. PubMed ID: 5812611
    [No Abstract]   [Full Text] [Related]  

  • 9. A morphological explanation of the transmission defect in myasthenia gravis.
    Simpson JA
    Ann N Y Acad Sci; 1971 Sep; 183():241-7. PubMed ID: 4330761
    [No Abstract]   [Full Text] [Related]  

  • 10. [My field of research--basic and applied neurophysiology].
    Buchthal F
    Nord Med; 1968 Jul; 80(27):867-77. PubMed ID: 4301011
    [No Abstract]   [Full Text] [Related]  

  • 11. The kinetics of transmitter release in myasthenia gravis. II. An electrophysiological analysis of the replenishment of transmitter stores.
    Bergmans J; Rosselle N; Verheyen G; Schellens L
    Electromyogr Clin Neurophysiol; 1973; 13(1):3-58. PubMed ID: 4353757
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurogenic changes in myasthenia gravis.
    Isaacs H; Badenhorst M
    S Afr Med J; 1974 Aug; 48(42):1783-9. PubMed ID: 4278873
    [No Abstract]   [Full Text] [Related]  

  • 13. The interaction of PCO2, pH and halothane on nerve action potentials.
    Ellis FR
    Br J Anaesth; 1968 Oct; 40(10):803. PubMed ID: 5725165
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mechanism of action of muscle relaxants and its clinical problems].
    Suzuki H
    Masui; 1974 Aug; 23(8):679-92. PubMed ID: 4372420
    [No Abstract]   [Full Text] [Related]  

  • 15. Factors governing speed of action potential conduction and neuromuscular transmission in aged rats.
    Smith DO; Rosenheimer JL
    Exp Neurol; 1984 Feb; 83(2):358-66. PubMed ID: 6319172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptomycin-induced neuromuscular fatigue in myasthenia gravis.
    Hokkanen E; Toivakka E
    Ann Clin Res; 1969 Nov; 1(3):220-6. PubMed ID: 4313111
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of aew intravenous narcotic, propanidid, in orthopedics and traumatology].
    Petterino E; Calogero G
    Minerva Ortop; 1968 Sep; 19(9):490-7. PubMed ID: 5742002
    [No Abstract]   [Full Text] [Related]  

  • 18. [Histological, histochemical and ultrastructural studies of the muscle and motor-nerve endings in myasthenia gravis and myasthenic syndromes].
    Fidziańska A; Jedrzejowska H; Kamieniecka Z
    Neurol Neurochir Pol; 1970; 4(3):311-21. PubMed ID: 5455381
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of high temperature on neuromuscular jitter in myasthenia gravis.
    Sener HO; Yaman A
    Eur Neurol; 2008; 59(3-4):179-82. PubMed ID: 18230876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of propranolol on the isolated phrenic nerve-diaphragm preparation of the rat.
    Paradelis AG; Theocharidis NC; Logaras G
    Arzneimittelforschung; 1973 Jan; 23(1):38-40. PubMed ID: 4353375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.